For example, similar to psoriasis, targeting Th2 cells, IL-4, and IL-13 have been the most efficacious (50–70%), and advanced therapy for AD40 and Janus kinase (JAK) inhibitors has been demonstrated to suppress the cytokine responses more effectively and are also a powerful treatment strategy for AD40. This evidence concerns the gene IL4 and psoriasis.